Moreover, expression was detected in specimens that encompassed the most curable (TEL-AML1), most common (normal cytogenetics) and poorest prognosis (Ph+) ALL subtypes (Table 1), although the quantitative expression of Hh pathway components did not correlate with any specific B-ALL subtype (data not shown). Here, RUNX1 is linked to acute lymphoblastic leukemia.